Valeant - Medpharma Division
- Launch of TheraPearl® (www.Therapearl.com) in GCC to generate USD5M, crafted full commercial plan with 5 years P&L for the region, from-scratch campaign & POSM in big retailers such as Boots® .
- Introduce TheraPearl® directly to consumer in addition to HCP detailing through trade marketing activations, outdoor advertising and TVC
- Re-branding of La Femme® -a personal hygiene product- in cooperation with R&D, QA and regulatory teams. Revamped outer & inner pack artwork, actual product & sample size plus 2 separate campaigns to HCP & DTC. Working with IML on mall branding & product dispensing at washrooms. Growth trend shows +37% vs last year in GNE.
- Assigned in collaboration with Valeant BDM to close the deal in commercializing Actipatch® (www.actipatch.com) in MENA region. Product is commercialized in 2017
- Manage Medpharma OTC Generics portfolio (USD9M) control P&L and OPEX. Portfolio includes Dandruff shampoo, baby cream, Antibiotic, cough syrups
- Support Medpharma market access strategies to new markets in North Africa through market research analysis & setting pricing strategies